20 Mar COVID-19 five years later: The impact on drug discovery
COVID-19 not only advanced scientific boundaries, but also transformed research methodologies and accelerated adaptive clinical trial design....
COVID-19 not only advanced scientific boundaries, but also transformed research methodologies and accelerated adaptive clinical trial design....
So far, it’s unknown why the test doesn’t perform uniformly across groups. The researchers suspect it has something to do with a harmless genetic variation that is more common in people of African, Caribbean, Middle Eastern and West Indian descent....
The simple addition of a deadline to a mailed invitation for fecal immunochemical test (FIT) colorectal cancer (CRC) screening resulted in improved return rates, the randomized TEMPO trial showed....
Ben Lengerich, an assistant professor in the Department of Statistics at UW–Madison, is on the forefront of this field, exploring and advancing the power of AI to predict and explain health outcomes. ...
Digital technologies have significantly transformed the landscape of clinical trials, revolutionizing the way they are designed, conducted, monitored, and analyzed....
The erosion of trust will devastate drug trial recruitment....
The study, “Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer’s disease,” examined brain scans from 601 participants enrolled in the Wisconsin Registry for Alzheimer’s Prevention and the Wisconsin Alzheimer’s Disease Research Center....
Following a stage IV colon cancer diagnosis and surgery, Scott Strege was eligible for a clinical trial that tested a combination of chemotherapy and a drug that cuts off blood supply to tumors....
Stephanie Sanders discusses her career path and current role as Project Coordinator within the UW Clinical Trials Institute....
It's much more than just dexamethasone works, hydroxychloroquine doesn't....